Time and again whytee these issues have been addressed, including the overwhelming commercial logic that like any intelligent profit-driven lender
Oaktree will want MSB alive not dead. It will want to maximise profits that way
whytee what are your commercial analytical credentials that you are so confident you can ignore this simple reality?
surely not just BA and some bylines? or is someone schooling you in the dark arts?
Cell Therapy News/Articles, page-16956
-
- There are more pages in this discussion • 865 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |